VSCPX
Price
$419.63
Change
-$6.24 (-1.47%)
Updated
Aug 18 closing price
Net Assets
183.38B
VVPSX
Price
$14.00
Change
-$0.06 (-0.43%)
Updated
Aug 18 closing price
Net Assets
81.76M
Interact to see
Advertisement

VSCPX vs VVPSX

VSCPX vs VVPSX Comparison Chart in %
View a ticker or compare two or three
VS
VSCPX vs. VVPSX commentary
Aug 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCPX is a Hold and VVPSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 183B vs. VVPSX (81.8M). VVPSX pays higher dividends than VSCPX: VVPSX (2.14) vs VSCPX (1.24). VSCPX was incepted earlier than VVPSX: VSCPX (16 years) vs VVPSX (17 years). VVPSX (1.45) is less costly to investors than VSCPX (0.02). VVPSX is a more actively managed with annual turnover of: 49.00 vs. VSCPX (17.00). VVPSX has a lower initial minimum investment than VSCPX: VVPSX (5000) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 25.27 vs. VVPSX (12.50). VSCPX return over 5 years is better than : 45.61 vs. VVPSX (-42.19).
VSCPXVVPSXVSCPX / VVPSX
Total Expense Ratio0.021.152%
Annual Report Gross Expense Ratio0.021.451%
Fund Existence16 years17 years-
Gain YTD19.59211.465171%
Front LoadN/AN/A-
Min. Initial Investment10000000050002,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets183B81.8M223,716%
Annual Yield % from dividends1.242.1458%
Returns for 1 year25.2712.50202%
Returns for 3 years59.2626.58223%
Returns for 5 years45.61-42.19-108%
Returns for 10 years161.83-15.11-1,071%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSZX29.59N/A
N/A
Alger Health Sciences Z
VRREX21.05N/A
N/A
Virtus Duff & Phelps Real Estate Secs R6
HIAGX25.74N/A
N/A
Hartford Disciplined Equity HLS IA
JVLIX30.17N/A
N/A
JHancock Disciplined Value I
GCSUX37.29N/A
N/A
Goldman Sachs Small Cap Eq Insghts R6